The nation’s leading dialysis testing lab will become the biggest single-site user of Siemens Healthineers Atellica Solution analyzers in the…
CAMBRIDGE, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically…
TransCon hGH (approved by the European Commission as Lonapegsomatropin Ascendis Pharma) is a once-weekly prodrug of somatropin for pediatric patients…
XIAMEN, China and HONG KONG, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Amoy Diagnostics Co., Ltd., (“AmoyDx”) and PREMIA Holdings (HK)…
Represents first step towards a potential clinical treatment of locally advanced pancreatic cancer LYON, France, January 13, 2022 -- EDAP TMS…
- First clinical combination study of BBP-398 and LUMAKRAS set to evaluate safety and preliminary efficacy in solid tumors with…
With the addition of psilocybin and MDMA to Health Canada’s Special Access Program, Mydecine looks to offer a package of…
SOUTH ORANGE, NJ, Jan. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology…
Headset data confirms Auxly almost doubled overall market share, ending the year as the #5 LP in Canada and continues…
TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a…